Adipose‐specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain
Konstantinos B. Sotiropoulos(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Motonobu Mastumoto(Joslin Diabetes Center), Kim Della Vecchia(Joslin Diabetes Center), Lloyd Paul Aiello(Joslin Diabetes Center), Junichi Takahashi(Joslin Diabetes Center), Christian Rask‐Madsen(University of Ulsan), Allen C. Clermont(Joslin Diabetes Center), Tatsuya Kondo(Kumamoto Medical Center), Yutaka Yasuda(Joslin Diabetes Center)
Cited by 81
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979